Federated Hermes Updates aTYR Pharma Stake in 13G/A Filing

Ticker: ATYR · Form: SC 13G/A · Filed: Jan 18, 2024 · CIK: 1339970

Atyr Pharma Inc SC 13G/A Filing Summary
FieldDetail
CompanyAtyr Pharma Inc (ATYR)
Form TypeSC 13G/A
Filed DateJan 18, 2024
Risk Levellow
Pages9
Reading Time11 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**Federated Hermes just updated their stake in aTYR Pharma, showing their latest holdings as of year-end 2023.**

AI Summary

Federated Hermes, Inc. filed an amended Schedule 13G/A on January 18, 2024, indicating their ownership in aTYR Pharma Inc. (NASDAQ: ATYR) as of December 31, 2023. This filing, Amendment No. 7, updates their previous disclosures regarding their holdings of aTYR Pharma's common stock. This matters to investors because it shows a significant institutional investor's continued, albeit potentially adjusted, stake in the company, which can influence market perception and liquidity.

Why It Matters

This filing confirms Federated Hermes, Inc. remains a notable institutional holder of aTYR Pharma stock, providing transparency into significant ownership changes that can impact investor confidence.

Risk Assessment

Risk Level: low — This is a routine update from an institutional investor and does not inherently signal a high-risk event for the company.

Analyst Insight

Investors should note Federated Hermes' continued, passive stake in aTYR Pharma, but this filing alone doesn't suggest immediate action. It's a routine disclosure of an institutional holding, not an active investment signal.

Key Players & Entities

  • Federated Hermes, Inc. (company) — the institutional investor filing the SC 13G/A
  • aTYR Pharma Inc. (company) — the subject company whose securities are being reported
  • December 31, 2023 (date) — the date of the event requiring the filing
  • January 18, 2024 (date) — the filing date of the SC 13G/A
  • Amendment No. 7 (number) — the specific amendment number of the filing

Forward-Looking Statements

  • Federated Hermes will continue to hold a significant, but passive, stake in aTYR Pharma. (Federated Hermes, Inc.) — high confidence, target: Q1 2025
  • The market will view Federated Hermes' continued ownership as a sign of long-term, albeit passive, confidence in aTYR Pharma. (aTYR Pharma Inc.) — medium confidence, target: Q2 2024

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under Rule 13d-1(b) of the Securities Exchange Act of 1934.

Who is the subject company whose securities are being reported?

The subject company is ATYR PHARMA, INC., with CUSIP Number 002120202.

Who is the entity that filed this SC 13G/A?

The entity that filed this SC 13G/A is FEDERATED HERMES, INC., with Central Index Key (CIK) 0001056288.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.

What is the business address of aTYR Pharma Inc.?

The business address of aTYR Pharma Inc. is 10240 Sorrento Valley Road, Suite 300, San Diego, CA 92121.

Filing Stats: 2,810 words · 11 min read · ~9 pages · Grade level 9.2 · Accepted 2024-01-18 10:17:40

Filing Documents

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. A. Federated Hermes, Inc. (a) Amount beneficially owned: 10,169,600 (b) Percent of class: 17.37% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 10,169,600 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 10,169,600 (iv)Shared power to dispose or to direct the disposition of: 0 B. Voting Shares Irrevocable Trust (a) Amount beneficially owned: 10,169,600 (b) Percent of class: 17.37% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 10,169,600 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 10,169,600 (iv)Shared power to dispose or to direct the disposition of: 0 C. Thomas R. Donahue (a) Amount beneficially owned: 10,169,600 (b) Percent of class: 17.37% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 10,169,600 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 10,169,600 D. Ann C. Donahue (a) Amount beneficially owned: 10,169,600 (b) Percent of class: 17.37% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 10,169,600 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 10,169,600 E. J. Christopher Donahue (a) Amount beneficially owned: 10,169,600 (b) Percent of class: 17.37% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Instruction: Dissolution of a group requires a response to this item.

Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE

Item 6. Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See Exhibit “1” Attached

Identification and Classification of Members of the Group: NOT APPLICABLE

Item 8. Identification and Classification of Members of the Group: NOT APPLICABLE

Notice of Dissolution of Group: NOT APPLICABLE

Item 9. Notice of Dissolution of Group: NOT APPLICABLE

Certification

Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to §240.13d-1(b); By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having the purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to §204.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title: J. Christopher Donahue, as President of Federated Hermes, Inc. Date: January 17, 2024 By: /s/Thomas R. Donahue Name/Title Thomas R. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/Ann C. Donahue Name/Title: Ann C. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title J. Christopher Donahue individually and as Trustee of Voting Shares Irrevocable Trust The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a

CLASSIFICATION OF REPORTING PERSONS

ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person IDENTITY CLASSIFICATION UNDER ITEM 3 Federated Hermes Equity Funds (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Hermes Insurance Series (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Equity Management Company of Pennsylvania (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Global Investment Management Corp. (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Hermes, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) FII Holdings, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Voting Shares Irrevocable Trust (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Thomas R. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Ann C. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) J. Christopher Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Federated Hermes, Inc. (the “Parent”) is filing this schedule 13G because it is the parent holding company of Federated Equity Management Company of Pennsylvania and Federated Global Investment Management Corp. (the “Investment Advisers”), which act as investment advisers to registered investment companies and separate accounts that own shares of common stock in ATYR PHARMA, INC. (the “Reported Securities”). The Investment Advisers are wholly owned subsidiaries of FII Holdings, Inc., which is wholly owned subsidiary of Federated Hermes, Inc., the

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.